Elixirgen Therapeutics, Inc.
Elixirgen Therapeutics, Inc.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate of EXG34217 in Patients With Telomere Biology Disorders With Bone Marrow Failure | Bone Marrow Failure, Bone Marrow Failure Disorders, Hemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder | Active, not recruiting | Phase 1 | 2026-02-06 | NCT04211714 | |
| Rollover Study From EXG-US-01 | Telomere Biology Disorders With Bone Marrow Failure | Enrolling by invitation | Phase 1 | 2024-07-12 | NCT05868499 |